MCM
AYTU icon

MAI Capital Management’s AYTU BioPharma AYTU Stock Holding History

MAI Capital Management’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.76K Hold
3,575
– – ﹤0.01% 3190
2025
Q4 		$9.29K Hold
3,575
– – ﹤0.01% 2888
2025
Q3 		$6.72K Hold
3,575
– – ﹤0.01% 2906
2025
Q2 		$7.79K Hold
3,575
– – ﹤0.01% 2862
2025
Q1 		$4.29K Hold
3,575
– – ﹤0.01% 2769
2024
Q4 		$6.08K Buy
+3,575
New +$6.53K ﹤0.01% 2708

Other funds holding AYTU

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CAM
Crown Advisors Management Larkspur, California $151M AUM 73.11% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $268M AUM 158.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MAI Capital Management's AYTU Position: Q1 2026 in Review

MAI Capital Management held its AYTU BioPharma (AYTU) position steady in Q1 2026 at 3,575 shares worth $9.76K. The position accounts for ﹤0.01% of the portfolio, ranked #3190.

MAI Capital Management first reported a position in AYTU in Q4 2024 and has held it in 6 quarters since. 37 funds tracked by Wall St. Rank hold AYTU as of Q1 2026.

  • MAI Capital Management held 3,575 shares of AYTU BioPharma worth $9.76K as of Q1 2026.
  • MAI Capital Management left its AYTU BioPharma share count unchanged in Q1 2026.
  • AYTU BioPharma made up ﹤0.01% of MAI Capital Management's portfolio in Q1 2026, its #3190 holding.
  • MAI Capital Management first reported a position in AYTU BioPharma in Q4 2024 and has held it in 6 quarters since.
  • 37 funds tracked by Wall St. Rank held AYTU BioPharma as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.